Mucor Circinelloides F. Lusitanicus

Generic Name: mucor circinelloides f. lusitanicus

Over-the-Counter (OTC)

Brand Names:

Mucor Circinelloides F. Lusitanicus

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: MUCOR CIRCINELLOIDES F. LUSITANICUS (.001 g/mL). Category: BLA.

Overview

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: MUCOR CIRCINELLOIDES F. LUSITANICUS (.001 g/mL). Category: BLA.

Dosage

Available as solution for intradermal, percutaneous, subcutaneous use.

Related Medications

Titanium Dioxide, Aluminum Hydroxide

titanium dioxide, aluminum hydroxide

Dosage form: LIQUID. Active ingredients: ALUMINUM HYDROXIDE (5 kg/100kg); TITANIUM DIOXIDE (45 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.

Apis Mellifica, Argentum Nitricum, Berberis Vulgaris, Cantharis, Equisetum Arvense, Kali Bichromicum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Phosphorus, Rhus Tox, Sepia, Terebinthina, Thuja Occidentalis

apis mellifica, argentum nitricum, berberis vulgaris, cantharis, equisetum arvense, kali bichromicum, lycopodium clavatum, mercurius solubilis, natrum muriaticum, phosphorus, rhus tox, sepia, terebinthina, thuja occidentalis

Standardized Insect Venom Allergenic Extract [EPC]

PURPOSE: Apis Mellifica – Kidney Support, Argentum Nitricum – Bladder Support, Berberis Vulgaris – Irregular Menses, Cantharis – Bladder Pain, Equisetum Arvense – Burning with Urination, Kali Bichromicum – Bladder Pain, Lycopodium Clavatum – Burning with Urination, Mercurius Solubilis – Bladder Support, Natrum Muriaticum – Kidney Support, Phosphorus – Irregular Menses, Rhus Tox – Bladder Pain, Sepia – Burning with Urination, Terebinthina – Kidney Support, Thuja Occidentalis – Burning with Urinat

Cemiplimab-rwlc

cemiplimab-rwlc

11 DESCRIPTION Cemiplimab-rwlc is a human programmed death receptor-1 (PD-1) blocking antibody. Cemiplimab-rwlc is a recombinant human IgG4 monoclonal antibody that binds to PD-1 and blocks its interaction with PD-L1 and PD-L2. Cemiplimab-rwlc is produced by recombinant DNA technology in Chinese hamster ovary (CHO) cell suspension culture. Cemiplimab-rwlc has an approximate molecular weight of 146 kDa.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.